Ketamine: A Magic Remedy
Author(s) -
K. Nuwal,
Sanjay Jain,
Kamal Singh Rathore
Publication year - 2018
Publication title -
pharmatutor
Language(s) - English
Resource type - Journals
eISSN - 2394-6679
pISSN - 2347-7881
DOI - 10.29161/pt.v6.i6.2018.24
Subject(s) - ketamine , depression (economics) , psychiatry , magic (telescope) , mood , safe haven , psychology , medicine , international economics , physics , quantum mechanics , economics , macroeconomics
The largest, longest study conducted on depression treatments, called the STAR*D trial, found that after people tried four antidepressants over the course of five years, about 70% of them were free of depressive symptoms. That’s a lot of trial and error to end at a place where 30% of patients don’t experience remission at all. The STAR*D trial ended in 2014, and despite a clear hole in the market–and a clear patient need–a golden age of new depression treatments still hasn’t arrived. The anesthetic ketamine could offer hope for people who don't have other depression treatment options. The most recent research on ketamine, as well as a statement from experts on its use published in April 2017, finds the drug works quickly, makes dramatic improvements in mood, and can work on people who haven’t gotten better with other depression treatments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom